InMode (INMD) Cash & Current Investments (2018 - 2026)

InMode (INMD) posted quarterly Cash & Current Investments of $480.1 million for Q1 2026, up 66.44% year-on-year from $288.5 million in Q1 2025, and up 1.79% on a QoQ basis from $471.7 million in Q4 2025.

InMode (INMD) Cash & Current Investments (2018 - 2026) Analysis & Trends

InMode (INMD) has reported Cash & Current Investments for 9 consecutive years, with $480.1 million the latest figure, recorded in Q1 2026.

  • Quarterly Cash & Current Investments rose 66.44% year-over-year to $480.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $480.1 million (up 66.44% YoY) and the FY2025 annual result came in at $471.7 million, up 43.47% from the prior year.
  • Cash & Current Investments rose to $480.1 million in Q1 2026 per INMD's latest filing, from $471.7 million in the prior quarter.
  • Over the last five years, Cash & Current Investments for INMD reached as high as $480.1 million in Q1 2026 and fell as low as $101.1 million in Q1 2022.
  • A 5-year average of $300.7 million and a median of $327.3 million in 2025 frame the typical range for Cash & Current Investments.
  • Annual changes were most pronounced in 2024 — Cash & Current Investments soared 125.01% — and 2025, when it dropped 24.04%.
  • Year by year, Cash & Current Investments stood at $172.8 million in 2022, then jumped by 112.95% to $368.0 million in 2023, then declined by 10.65% to $328.8 million in 2024, then surged by 43.47% to $471.7 million in 2025, then increased by 1.79% to $480.1 million in 2026.
  • According to Business Quant data, Cash & Current Investments over the past three periods registered $480.1 million, $471.7 million, and $410.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn 7.30 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn 2.88 Bn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn 9.22 Bn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn 1.45 Bn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn 3.67 Bn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn 1.12 Bn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn 2.29 Bn
8 Smith & Nephew 26.99 Bn 26.41 Bn - 577.00 Mn
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn 3.12 Bn
10 InMode 981,130.50 -479.15 Mn 61.55 Mn 480.13 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 480.13 Mn
Dec 31, 2025 471.70 Mn
Sep 30, 2025 410.79 Mn
Jun 30, 2025 327.30 Mn
Mar 31, 2025 288.47 Mn
Dec 31, 2024 328.78 Mn
Sep 30, 2024 403.43 Mn
Jun 30, 2024 395.69 Mn
Mar 31, 2024 379.76 Mn
Dec 31, 2023 367.96 Mn
Sep 30, 2023 289.99 Mn
Jun 30, 2023 228.95 Mn
Mar 31, 2023 168.78 Mn
Dec 31, 2022 172.79 Mn
Sep 30, 2022 151.45 Mn
Jun 30, 2022 144.32 Mn
Mar 31, 2022 101.06 Mn
Dec 31, 2021 121.38 Mn
Sep 30, 2021 122.15 Mn
Jun 30, 2021 114.03 Mn